Canada’s Drug Agency | Drugs, Health Technologies and Systems.
Canada’s Drug Agency | Drugs, Health Technologies and Systems.

Combined Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza

Details

Files
Project Status:
Completed
Project Line:
Horizon Scan
Project Sub Line:
Health Technology Update
Project Number:
EN0029-000

This report looks at the current evidence regarding diagnostic tests that can detect both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, the virus that causes COVID-19 infection) and seasonal influenza. Combined diagnostic tests can be used to detect both viruses from 1 respiratory sample in a single reaction. The availability of these tests, their cost, and current practice are explored in this Horizon Scan.

Files

Combined Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Influe… View PDF
Last Updated : June 30, 2021